{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T19:36:17Z","timestamp":1776972977550,"version":"3.51.4"},"reference-count":27,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,3,3]],"date-time":"2022-03-03T00:00:00Z","timestamp":1646265600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Physiol."],"abstract":"<jats:p>Partial deficiency of the last enzyme of the heme biosynthetic pathway, namely, ferrochelatase (FECH), is responsible for erythropoietic protoporphyria (EPP) in humans. This disorder is characterized by painful skin photosensitivity, due to excessive protoporphyrin IX (PPIX) production in erythrocytes. Although several papers report the presence of iron deficiency anemia in about 50% of EPP patients, there is still no a conclusive explanation of the why this occurs. In the present work, we explored hematological indices and iron status in 20 unrelated Italian EPP patients in order to propose a new hypothesis. Our data show that microcytosis is present in EPP patients also in the absence of anemia and iron deficiency with a link between PPIX accumulation and reduced MCV, probably indicating an indirect condition of heme deficiency. Patients studied had a downward shift of iron parameters due to increased hepcidin concentrations only in a state of repleted iron stores. Interestingly, hemoglobin synthesis was not limited by iron supply except in cases with further iron loss, in which concomitantly increased soluble transferrin (Tf) receptor (sTfR) levels were detected. The mechanisms involved in the iron uptake downregulation in EPP remain unclear, and the role of PPIX accumulation in microcytosis.<\/jats:p>","DOI":"10.3389\/fphys.2022.841050","type":"journal-article","created":{"date-parts":[[2022,3,3]],"date-time":"2022-03-03T10:17:26Z","timestamp":1646302646000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Microcytosis in Erythropoietic Protoporphyria"],"prefix":"10.3389","volume":"13","author":[{"given":"Giovanna","family":"Graziadei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorena","family":"Duca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Granata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giacomo","family":"De Luca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"De Giovanni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentina","family":"Brancaleoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabella","family":"Nava","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Di Pierro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,3,3]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1136\/gut.2006.097576","article-title":"Liver disease in erythropoietic protoporphyria: insights and implications for management","volume":"56","author":"Anstey","year":"2007","journal-title":"Gut"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.ymgme.2019.01.020","article-title":"Erythropoietic Protoporphyria and X-linked Protoporphyria: pathophysiology, genetics, clinical manifestations, and management","volume":"128","author":"Balwani","year":"2019","journal-title":"Mol. Genet. Metab."},{"key":"ref001","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1001\/jamadermatol.2017.1557","article-title":"Clinical, biochemical, and genetic characterization of North American patients with erythropoietic protoporphyria and X-linked protoporphyria","volume":"153","author":"Balwani","year":"2017","journal-title":"JAMA Dermatol."},{"key":"ref007","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.bcmd.2013.05.008","article-title":"Iron availability modulates aberrant splicing of ferrochelatase through the iron- and 2-oxoglutarate dependent dioxygenase Jmjd6 and U2AF65","volume":"51","author":"Barman-Aksozen","year":"2013","journal-title":"Blood Cells Mol. Dis."},{"key":"ref3","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s10545-017-0017-7","article-title":"Disturbed iron metabolism in erythropoietic protoporphyria and association of GDF15 and gender with disease severity","volume":"40","author":"Barman-Aksoezen","year":"2017","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref4","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.ymgme.2019.04.013","article-title":"Delta-aminolevulinic acid synthase 2 expression in combination with iron as modifiers of disease severity in erythropoietic protoporphyria","volume":"128","author":"Barman-Aksozen","year":"2019","journal-title":"Mol. Genet. Metab."},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1111\/eci.12503","article-title":"Homeostasis of iron and hepcidin in erythropoietic protoporphyria","volume":"45","author":"Bossi","year":"2015","journal-title":"Eur. J. Clin. Investig."},{"key":"ref008","doi-asserted-by":"publisher","first-page":"272","DOI":"10.3390\/diagnostics12020272","article-title":"Iron in porphyrias: friend or foe?","volume":"12","author":"Buzzetti","year":"2022","journal-title":"Diagnostics"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/s41436-019-0584-0","article-title":"Targeted resequencing of FECH locus reveals that a novel deep intronic pathogenic variant and eQTLs may cause erythropoietic protoporphyria (EPP) through a methylation-dependent mechanism","volume":"22","author":"Chiara","year":"2020","journal-title":"Genet. Med."},{"key":"ref7","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1093\/ajcn\/32.10.2115","article-title":"Assessing iron status of a population","volume":"32","author":"Cook","year":"1979","journal-title":"Am. J. Clin. Nutr."},{"key":"ref8","first-page":"45","article-title":"Excessive erythrocyte PPIX influences the hematologic status and iron metabolism in patients with dominant erythropoietic protoporphyria","volume":"55","author":"Delaby","year":"2009","journal-title":"Cell Mol. Biol."},{"key":"ref002","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3390\/diagnostics12010151","article-title":"Recognized and emerging features of erythropoietic and X-linked protoporphyria","volume":"12","author":"Di Pierro","year":"2022","journal-title":"Diagnostics"},{"key":"ref009","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.3390\/diagnostics11081343","article-title":"Laboratory diagnosis of porphyria","volume":"11","author":"Di Pierro","year":"2021","journal-title":"Diagnostics"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"8160","DOI":"10.1182\/blood-2006-04-014142","article-title":"Hepcidin: a putative iron-regulatory hormone relevant to hereditary hemochromatosis and the anemia of chronic disease","volume":"98","author":"Fleming","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1152\/physrev.00008.2013","article-title":"Systemic iron homeostasis","volume":"93","author":"Ganz","year":"2013","journal-title":"Physiol. Rev."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/ng809","article-title":"The penetrance of dominant erythropoietic protoporphyria is modulated by expression of wildtype FECH","volume":"30","author":"Gouya","year":"2002","journal-title":"Nat. Genet."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"4108","DOI":"10.1182\/blood-2007-04-088120","article-title":"Erythropoiesis and iron metabolism in dominant erythropoietic protoporphyria","volume":"110","author":"Holme","year":"2007","journal-title":"Blood"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.clinre.2015.05.009","article-title":"Porphyrias: A 2015 update","volume":"39","author":"Karim","year":"2015","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1750-1172-4-19","article-title":"Erythropoietic protoporphyria","volume":"4","author":"Lecha","year":"2009","journal-title":"Orphanet J. Rare Dis."},{"key":"ref15","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1182\/blood-2006-04-014142","article-title":"Increased plasma transferrin, altered body iron distribution, and microcytic hypochromic anemia in ferrochelatase-deficient mice","volume":"109","author":"Lyoumi","year":"2007","journal-title":"Blood"},{"key":"ref003","doi-asserted-by":"publisher","first-page":"798","DOI":"10.3390\/metabo11120798","article-title":"Iron, heme synthesis and erythropoietic porphyrias: a complex interplay","volume":"11","author":"Poli","year":"2021","journal-title":"Metabolites"},{"key":"ref005","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1016\/j.bbadis.2015.03.011","article-title":"An overview of molecular basis of iron metabolism regulation and the associated pathologies","volume":"1852","author":"Silva","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1182\/blood.V75.9.1870.1870","article-title":"Serum transferrin receptor: a quantitative measure of tissue iron deficiency","volume":"75","author":"Skikne","year":"1990","journal-title":"Blood"},{"key":"ref006","doi-asserted-by":"publisher","first-page":"4685","DOI":"10.1046\/j.1432-1327.2000.01519.x","article-title":"Regulation of the expression of human ferrochelatase by intracellular iron levels","volume":"267","author":"Taketani","year":"2000","journal-title":"Eur. J. Biochem."},{"key":"ref17","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1097\/MOH.0b013e328337b52f","article-title":"Growth differentiation factor 15 in erythroid health and disease","volume":"17","author":"Tanno","year":"2010","journal-title":"Curr. Opin. Hematol."},{"key":"ref18","doi-asserted-by":"publisher","first-page":"151859","DOI":"10.1016\/j.anndiagpath.2021.151859","article-title":"Liver involvement in patients with erythropoietic protoporphyria","volume":"56","author":"Wensink","year":"2021","journal-title":"Dig. Liver Dis."},{"key":"ref004","doi-asserted-by":"publisher","first-page":"176","DOI":"10.3389\/fphar.2014.00176","article-title":"The IRP\/IRE system in vivo: insights from mouse models","volume":"5","author":"Wilkinson","year":"2014","journal-title":"Front. Pharmacol."}],"container-title":["Frontiers in Physiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphys.2022.841050\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,3]],"date-time":"2022-03-03T10:17:29Z","timestamp":1646302649000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphys.2022.841050\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,3]]},"references-count":27,"alternative-id":["10.3389\/fphys.2022.841050"],"URL":"https:\/\/doi.org\/10.3389\/fphys.2022.841050","relation":{},"ISSN":["1664-042X"],"issn-type":[{"value":"1664-042X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,3]]},"article-number":"841050"}}